Earnings Call · Q4 FY2023·2024-03-06

Q4 23EPS -25.00%·Rev n/aQ3 23EPS +69.23%·Rev n/aQ2 23EPS +22.64%·Rev n/aQ1 23EPS -47.06%·Rev n/a⚠ consensus missing

TALPHERA, INC. TLPH

Raffi Asadorian — Chief Financial Officer

Vincent Angotti — Chief Executive Officer

Pamela Palmer — Clinical Study Lead / Medical Officer

+20.9%1d on move date+20.6% vs SPY3d+14.3%5d+31.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TLPH calls or request research access.

More TLPH calls Browse calls Request research access